Evidence map›Paper›PMID 34850206›Full record

ArticleNeuro-oncology2022

Corrigendum to: Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.

Alberto Iannalfi, Emma D'Ippolito, Giulia Riva, Silvia Molinelli, Sara Gandini, Gisela Viselner, Maria Rosaria Fiore, Barbara Vischioni, Viviana Vitolo, Maria Bonora and 13 more

Abstract readPublished Erratum
In one paragraph

Article in Neuro-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Alberto IannalfiClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.ORCID 0000-0003-2425-4278
Emma D'IppolitoClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Giulia RivaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Silvia MolinelliClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Sara GandiniDepartment of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Gisela ViselnerClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Maria Rosaria FioreClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Barbara VischioniClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Viviana VitoloClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Maria BonoraClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Sara RonchiClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Rachele PetrucciClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Amelia BarcelliniClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Alfredo MirandolaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Stefania RussoClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Alessandro VaiClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Edoardo MastellaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Giuseppe MagroClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Davide MaestriClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Mario CioccaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Lorenzo PredaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Francesca ValvoClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Roberto OrecchiaClinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34850206
PMCPMC9340626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.